Alexza’s Acute-Panic Drug Fails In Phase IIa
Inhaled therapy missed both primary endpoints, but lead candidate has finished Phase III schizophrenia enrollment early.
Inhaled therapy missed both primary endpoints, but lead candidate has finished Phase III schizophrenia enrollment early.